Andrew James Aguirre

Dana-Farber Cancer Inst

$4,144,301

Attributed

$7,111,188

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY2017–25

$2.5M$1.9M$1.3M$625K$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$7,111,188 · 4

By mechanism

U01$4,096,241 · 1

R01$2,129,347 · 2

K08$885,600 · 1

Top collaborators

Most similar at Dana-Farber Cancer Inst

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Tumor”

Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213

Research focus

TumorResponseMalignant Neoplasm Of PancreasClinical TrialsProgramsPancreatic Ductal AdenocarcinomaSignal TransductionCellsPharmaceutical PreparationsMemberIn VitroGenomic ApproachInvestigationMalignant NeoplasmsPathway InteractionsIn VivoFunctional GenomicsGenetic TranscriptionNeoplastic CellGenetic ScreeningGene ExpressionGeneticCancer CellCombined Modality Therapy